49
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Frailty, a critical intermediate status of the aging process that is at increased risk for negative health-related events, includes physical, cognitive, and psychosocial domains or phenotypes. Cognitive frailty is a condition recently defined by operationalized criteria describing coexisting physical frailty and mild cognitive impairment (MCI), with two proposed subtypes: potentially reversible cognitive frailty (physical frailty/MCI) and reversible cognitive frailty (physical frailty/pre-MCI subjective cognitive decline). In the present article, we reviewed the framework for the definition, different models, and the current epidemiology of cognitive frailty, also describing neurobiological mechanisms, and exploring the possible prevention of the cognitive frailty progression. Several studies suggested a relevant heterogeneity with prevalence estimates ranging 1.0–22.0% (10.7–22.0% in clinical-based settings and 1.0–4.4% in population-based settings). Cross-sectional and longitudinal population-based studies showed that different cognitive frailty models may be associated with increased risk of functional disability, worsened quality of life, hospitalization, mortality, incidence of dementia, vascular dementia, and neurocognitive disorders. The operationalization of clinical constructs based on cognitive impairment related to physical causes (physical frailty, motor function decline, or other physical factors) appears to be interesting for dementia secondary prevention given the increased risk for progression to dementia of these clinical entities. Multidomain interventions have the potential to be effective in preventing cognitive frailty. In the near future, we need to establish more reliable clinical and research criteria, using different operational definitions for frailty and cognitive impairment, and useful clinical, biological, and imaging markers to implement intervention programs targeted to improve frailty, so preventing also late-life cognitive disorders.

          Related collections

          Most cited references86

          • Record: found
          • Abstract: found
          • Article: not found

          A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder.

          Recurrent-episode Major Depressive Disorder (MDD) is associated with a number of neuropsychological deficits. To date, less is known about whether these are present in the first-episode. The current aim was to systematically evaluate the literature on first-episode MDD to determine whether cognition may be a feasible target for early identification and intervention. Electronic database searches were conducted to examine neuropsychological studies in adults (mean age greater than 18 years old) with a first-episode of MDD. Effect sizes were pooled by cognitive domain. Using meta-regression techniques, demographic and clinical factors potentially influencing heterogeneity of neuropsychological outcome were also investigated. The 15 independent samples reviewed yielded data for 644 patients with a mean age of 39.36 years (SD=10.21). Significant cognitive deficits were identified (small to medium effect sizes) for psychomotor speed, attention, visual learning and memory, and all aspects of executive functioning. Symptom remission, inpatient status, antidepressant use, age and educational attainment, each significantly contributed to heterogeneity in effect sizes in at least one cognitive domain. Reviewed studies were limited by small sample sizes and often did not report important demographic and clinical characteristics of patients. The current meta-analysis was the first to systematically demonstrate reduced neuropsychological functioning in first-episode MDD. Psychomotor speed and memory functioning were associated with clinical state, whereas attention and executive functioning were more likely trait-markers. Demographic factors were also associated with heterogeneity across studies. Overall, cognitive deficits appear to be feasible early markers and targets for early intervention in MDD. Copyright © 2011 Elsevier B.V. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Adipose tissue as an immunological organ.

            This review will focus on the immunological aspects of adipose tissue and its potential role in development of chronic inflammation that instigates obesity-associated comorbidities.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions

                Bookmark

                Author and article information

                Journal
                J Alzheimers Dis
                J. Alzheimers Dis
                JAD
                Journal of Alzheimer's Disease
                IOS Press (Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands )
                1387-2877
                1875-8908
                13 March 2018
                2018
                : 62
                : 3 , Special 20th Anniversary Issue
                : 993-1012
                Affiliations
                [a ]Department of Medical Sciences, Geriatric Unit and Laboratory of Gerontology and Geriatrics , IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Foggia, Italy
                [b ]Department of Basic Medicine, Neurodegenerative Disease Unit, Neuroscience, and Sense Organs, University of Bari Aldo Moro , Bari, Italy
                [c ]Department of Clinical Research in Neurology, University of Bari Aldo Moro , “Pia Fondazione Cardinale G. Panico”, Tricase, Lecce, Italy
                [d ]Geriatric Medicine-Memory Unit and Rare Disease Centre, University of Bari “Aldo Moro” , Bari, Italy
                [e ]National Institute of Gastroenterology “Saverio de Bellis” , Research Hospital, Castellana Grotte Bari, Italy
                [f ]Interdisciplinary Department of Medicine (DIM), Section of Dentistry, University of Bari Aldo Moro , Bari, Italy
                [g ]Department of Clinical and Experimental Medicine, Psychiatric Unit, University of Foggia , Foggia, Italy
                [h ]Otolaryngology Unit, University of Bari Aldo Moro , Italy
                [i ]Institute of Neurology, Catholic University of Sacred Heart , Rome, Italy
                Author notes
                [1]

                These authors contributed equally to this work.

                [* ]Correspondence to: Francesco Panza, MD, PhD, Geriatric Unit and Laboratory of Gerontology and Geriatrics, Department of Medical Sciences, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Foggia, Italy and Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy and Department of Clinical Research in Neurology, University of Bari Aldo Moro, “Pia Fondazione Cardinale G. Panico”, Tricase, Lecce, Italy. Tel.: +39 0882 410271; Fax.: +39 0882 410271; E-mail: geriat.dot@ 123456uniba.it and Madia Lozupone, MD, Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy. Email: madia.lozupone@ 123456gmail.com .
                Article
                JAD170963
                10.3233/JAD-170963
                5870024
                29562543
                5627984f-195c-4b08-b5fb-7bd412f612ed
                © 2018 – IOS Press and the authors. All rights reserved

                This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 8 December 2017
                Categories
                Review

                alzheimer’s disease,biomarkers,dementia,frailty,lifestyle,mild cognitive impairment,nutrition,prevention,subjective cognitive decline,vascular dementia

                Comments

                Comment on this article